Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
|
Mid-range Performer
1219.5000
8.10
(
0.67
%)
NSE
Aug 11, 2025
15:31 PM
Volume:
1.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
30 Oct 2023
1219.50
0.67%
Dr. Reddy's Hyderabad plant handed 10 US FDA observations
Moneycontrol
This was a routine cGMP inspection at our formulations manufacturing facility (FTO-3) in Hyderabad.
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 29 Jul, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
IPO action stays active with four new issues and six listings this week
|
11 Aug 2025, 06:17PM
Market closes higher, L&T wins an order worth over Rs 15,000 crore from Adani Power
Trendlyne Marketwatch |
11 Aug 2025, 03:56PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021